Report overview
Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities.
This report aims to provide a comprehensive presentation of the global market for Autism Spectrum Disorder Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autism Spectrum Disorder Diagnostics. This report contains market size and forecasts of Autism Spectrum Disorder Diagnostics in global, including the following market information:
Global Autism Spectrum Disorder Diagnostics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Autism Spectrum Disorder Diagnostics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Autistic Disorder Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Autism Spectrum Disorder Diagnostics include Pfizer, Merck, Roche, SynapDx and Curemark, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Autism Spectrum Disorder Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Autism Spectrum Disorder Diagnostics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Autism Spectrum Disorder Diagnostics Market Segment Percentages, by Type, 2022 (%)
Autistic Disorder
Asperger Syndrome
Childhood Disintegrative Disorder
Others
Global Autism Spectrum Disorder Diagnostics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Autism Spectrum Disorder Diagnostics Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Autism Spectrum Disorder Diagnostics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Autism Spectrum Disorder Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Autism Spectrum Disorder Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Autism Spectrum Disorder Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Merck
Roche
SynapDx
Curemark
Outline of Major Chapters:
Chapter 1: Introduces the definition of Autism Spectrum Disorder Diagnostics, market overview.
Chapter 2: Global Autism Spectrum Disorder Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Autism Spectrum Disorder Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Autism Spectrum Disorder Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
